Entity coverage

iShares Biotechnology ETF

IBB · 17 events mapped

Market Ontology has mapped 17 distinct macro, policy, and market events to IBB. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-07-14EventIncreased funding for a biotech company, potentially signaling investor confidence in the broader biotech sector, especially in neurological disorders.
  • 2026-07-04EventGeneral sentiment indicator for the biotech sector; large capital raises can signal investor confidence or, conversely, a need for cash in a challenging environment.
  • 2026-06-29EventSimilar to XBI, IBB provides broad exposure to the biotechnology sector. M&A activity can influence overall sector sentiment and valuations.
  • 2026-06-29EventGeneral sentiment towards biotech M&A, potential for sector-wide re-rating of similar assets.
  • 2026-06-25EventSimilar to XBI, positive news from a constituent company can provide a minor uplift to the broader biotechnology sector ETF.
  • 2026-06-23EventPositive sentiment for the broader biotechnology sector due to successful capital raise for a pre-clinical/early-clinical stage company, indicating investor confidence.
  • 2026-06-23EventSuccessful IPOs can signal broader investor appetite for the biotechnology sector, potentially influencing sentiment for related ETFs.
  • 2026-06-23EventVery minor negative sentiment spillover due to a constituent company's bankruptcy, potentially increasing risk aversion in the broader biotech sector.

Continuous coverage for IBB with alerts, structural playbooks, and options routing lives in the platform. Start a trial →